247 related articles for article (PubMed ID: 34481731)
1. FKBP51 and the molecular chaperoning of metabolism.
Smedlund KB; Sanchez ER; Hinds TD
Trends Endocrinol Metab; 2021 Nov; 32(11):862-874. PubMed ID: 34481731
[TBL] [Abstract][Full Text] [Related]
2. The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.
Fries GR; Gassen NC; Rein T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206196
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51.
Westberry JM; Sadosky PW; Hubler TR; Gross KL; Scammell JG
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):34-41. PubMed ID: 16723223
[TBL] [Abstract][Full Text] [Related]
4. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
[TBL] [Abstract][Full Text] [Related]
5. FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.
Gan YL; Wang CY; He RH; Hsu PC; Yeh HH; Hsieh TH; Lin HC; Cheng MY; Jeng CJ; Huang MC; Lee YH
J Neuroinflammation; 2022 Jun; 19(1):152. PubMed ID: 35705957
[TBL] [Abstract][Full Text] [Related]
6. Steroid up-regulation of FKBP51 and its role in hormone signaling.
Jääskeläinen T; Makkonen H; Palvimo JJ
Curr Opin Pharmacol; 2011 Aug; 11(4):326-31. PubMed ID: 21531172
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens.
Park J; Kim M; Na G; Jeon I; Kwon YK; Kim JH; Youn H; Koo Y
Mol Cell Endocrinol; 2007 Nov; 278(1-2):7-17. PubMed ID: 17870233
[TBL] [Abstract][Full Text] [Related]
8. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness.
Zhang X; Clark AF; Yorio T
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1037-47. PubMed ID: 18326728
[TBL] [Abstract][Full Text] [Related]
9. FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.
Stechschulte LA; Hinds TD; Khuder SS; Shou W; Najjar SM; Sanchez ER
Mol Endocrinol; 2014 Aug; 28(8):1265-75. PubMed ID: 24933247
[TBL] [Abstract][Full Text] [Related]
10. Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation.
Toneatto J; Guber S; Charó NL; Susperreguy S; Schwartz J; Galigniana MD; Piwien-Pilipuk G
J Cell Sci; 2013 Dec; 126(Pt 23):5357-68. PubMed ID: 24101724
[TBL] [Abstract][Full Text] [Related]
11. FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
Stechschulte LA; Sanchez ER
Curr Opin Pharmacol; 2011 Aug; 11(4):332-7. PubMed ID: 21565552
[TBL] [Abstract][Full Text] [Related]
12. [The dynamic mitochondria-nuclear redistribution of FKBP51 during the process of adipocyte differentiation is regulated by PKA].
Toneatto J; Charó NL; Susperreguy S; Piwien-Pilipuk G
Medicina (B Aires); 2013; 73(5):401-5. PubMed ID: 24152393
[TBL] [Abstract][Full Text] [Related]
13. FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes.
Sidibeh CO; Pereira MJ; Abalo XM; J Boersma G; Skrtic S; Lundkvist P; Katsogiannos P; Hausch F; Castillejo-López C; Eriksson JW
Endocrine; 2018 Oct; 62(1):116-128. PubMed ID: 30032404
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.
Fries GR; Vasconcelos-Moreno MP; Gubert C; dos Santos BT; Sartori J; Eisele B; Ferrari P; Fijtman A; Rüegg J; Gassen NC; Kapczinski F; Rein T; Kauer-Sant'Anna M
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25522387
[TBL] [Abstract][Full Text] [Related]
15. InterAKTions with FKBPs--mutational and pharmacological exploration.
Fabian AK; März A; Neimanis S; Biondi RM; Kozany C; Hausch F
PLoS One; 2013; 8(2):e57508. PubMed ID: 23469007
[TBL] [Abstract][Full Text] [Related]
16. FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.
Stechschulte LA; Hinds TD; Ghanem SS; Shou W; Najjar SM; Sanchez ER
Mol Endocrinol; 2014 Aug; 28(8):1254-64. PubMed ID: 24933248
[TBL] [Abstract][Full Text] [Related]
17. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.
Scammell JG; Denny WB; Valentine DL; Smith DF
Gen Comp Endocrinol; 2001 Nov; 124(2):152-65. PubMed ID: 11703081
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Fkbp4 and Fkbp5 on Regulation of the
Kageyama K; Iwasaki Y; Watanuki Y; Niioka K; Daimon M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072036
[TBL] [Abstract][Full Text] [Related]
20. Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine.
Gassen NC; Fries GR; Zannas AS; Hartmann J; Zschocke J; Hafner K; Carrillo-Roa T; Steinbacher J; Preißinger SN; Hoeijmakers L; Knop M; Weber F; Kloiber S; Lucae S; Chrousos GP; Carell T; Ising M; Binder EB; Schmidt MV; Rüegg J; Rein T
Sci Signal; 2015 Nov; 8(404):ra119. PubMed ID: 26602018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
